Skip to content

Vitamin C in Children with Septic Shock- A Randomised Controlled Trial

Vitamin C versus Placebo in Pediatric Septic Shock (VITACiPS)- A Randomised Controlled Trial - VITACiPS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022886
Enrollment
218
Registered
2020-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I959- Hypotension, unspecified

Interventions

Intervention1: Vitamin C: In addition to standard protocol for management of septic shock, Vitamin C will be administered at a dose of 25 mg/kg at 6 hourly intervals. Control Intervention1: Placebo: I

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children 2 months to = 17 years of age admitted to the ICU with a diagnosis of septic shock

Exclusion criteria

Exclusion criteria: 1. Children with chronic kidney disease. 2. Children with fulminant myocarditis 3. Children with dengue shock syndrome 4. Children on Vitamin C or Thiamine or steroid supplements 5. Children on anticancer drugs, drugs for autoimmune diseases 6. Children with G6PD deficiency 7. Children on iron supplements for iron deficiency anemia (can exaggerate iron absorption, iron overload and tissue damage) 8. Post-arrest shock and cardiac dysfunction 9. Moribund patients in who anticipated survival is

Design outcomes

Primary

MeasureTime frame
1. Change in P-SOFA score at 72 hours from P-SOFA scores at the time of enrollment (referred to as ‘0’ hour score)Timepoint: 1. 72 hours of enrollment

Secondary

MeasureTime frame
MortalityTimepoint: 28 day mortality

Countries

India

Contacts

Public ContactJhuma Sankar

All India Institute of Medical Sciences

jhumaji@gmail.com01126546784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026